Novo Nordisk (or 'the company') is a leading global provider of diabetes products. The company also has a leadership position in hemostasis management, growth hormone therapy and hormone replacement therapy. Novo Nordisk operates in Europe, North America, China, Japan, Korea and other regions of the world. It is headquartered in Bagsvaerd, Denmark, and employed 41,450 people as of December 31, 2014.

Published By MarketLine

H. Lundbeck A/S (Lundbeck or 'the company') is a specialty pharmaceutical company primarily focusing in the field of psychiatric and neurological disorders. The company's majority of operations are in the Americas and Europe. It is headquartered in Valby, Denmark and employed 5,530 people as of December 31, 2013.

Published By MarketLine

Genmab (or 'the company') is a biotechnology company engaged in the discovery and development of human antibodies for the treatment of life-threatening and debilitating diseases. The company's therapeutic emphasis is in the areas of cancer, infectious diseases, rheumatoid arthritis and other inflammatory conditions. It is headquartered in Copenhagen, Denmark and employed 157 people as of December 31, 2013.

Published By MarketLine

Coloplast (or 'the company') is a leading supplier of products for ostomy care, urology and continence care, dressings for the treatment of chronic wounds, and skin care products for prevention and treatment. The company operates in Europe and other regions of the world. It is headquartered in Humlebaek, Denmark, and employed 9,250 people as of September 30, 2014.

Published By MarketLine

ALK-Abello (or 'the group') is a Denmark-based pharmaceutical group engaged in the development and marketing of allergy treatment products. The group operates in Europe, North America and other parts of the world. It is headquartered in Horsholm, Denmark, and employed 1,763 people as on December 31, 2013.